BioSpace News Archive

CVD Equipment Corporation announced its first quarter 2019 financial results.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2019.

A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and that treatment could help reduce cases of cardiovascular disease, the leading cause of death in the U.S.

Veracyte, Inc. announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the UBS Global Healthcare Conference in New York City on Monday, May 20, 2019 at 9:30 a.m. EDT.

Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, announced a poster presentation at the Society for Investigative Dermatology Meeting, May 8-11, in Chicago.

Demonstrating its advocacy for genomics research, Integrated DNA Technologies (IDT) announces a significant expansion to its NGS portfolio. The company is excited to launch a uniqueCustom NGS Adapters offering, becoming the only genomics provider to provide an easy and flexible customized adapter solution directly to scientists.

Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of the Atlantic® ReadyDisk® product family - solid phase extraction (SPE) disks, pre-assembled into single-use holders, for extracting semi-volatile organic compounds from aqueous samples.

Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced first quarter 2019 financial results.

Atelerix, creator of an innovative cell encapsulation technology, today announces it has closed a second round of funding of £700,000 to accelerate development of its cell transport products to market.

Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company.